1-4 of 4
Maria Teresa Pirrotta
Close
Sort by
Journal Articles

Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0)

Francesco Forconi, MD, Emanuele Cencini, Davide Rossi, Riccardo Bomben, Elisa Sozzi, Marta Coscia, MD, PhD, Massimo Massaia, MD, Silvio Veronese, Alessandra Tedeschi, Marco Montillo, Rita Fazzi, Mario Petrini, MD, Stefania Ciolli, MD, Alberto Bosi, Roberto Dottori, Maria Teresa Pirrotta, Alessandra Caremani, Giovanni Del Poeta, Ilaria Del Giudice, MD, Simona Santangelo, PhD, Luca Laurenti, MD, Dimitar G Efremov, Livio Trentin, Luca Arcaini, MD, Ester Orlandi, MD, Francesco Bertoni, Rossana Maffei, Robin Foà, MD, Roberto Marasca, Valter Gattei, Gianluca Gaidano, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 1371.
https://doi.org/10.1182/blood.V116.21.1371.1371
Published: 2010
Journal Articles

Phase II Pilot Study of Gemtuzumab Ozogamicin (GO), Fludarabine, Cytarabine and Idarubicin Combined Regimen as Induction Therapy Plus GO Alone as Consolidation Therapy for Elderly Acute Myeloid Leukemia Patients.

Maria Teresa Pirrotta, MD, Monica Bocchia, MD, Alessandro Bucalossi, MD, Marzia Defina, MD, Francesco Forconi, MD, Simona Sammassimo, MD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 4613.
https://doi.org/10.1182/blood.V106.11.4613.4613
Published: 2005
Journal Articles

Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Simona Calabrese, BS, Alessandro Gozzetti, MD, Maria Teresa Pirrotta, MD, Rosaria Crupi, BS, Daniela Tozzuoli, PhD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 1999.
https://doi.org/10.1182/blood.V106.11.1999.1999
Published: 2005
Journal Articles

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Maria Teresa Pirrotta, MD, Malgorzata M. Trawinska, MD, Marilina Amabile, PhD, Giovanni Martinelli, MD, Francesco Forconi, MD, Alessandro Gozzetti, MD, Angelo M. Carella, MD, Donatella Raspadori, PhD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 167.
https://doi.org/10.1182/blood.V106.11.167.167
Published: 2005